NDC 51285-047

Ziac

Bisoprolol Fumarate And Hydrochlorothiazide

Ziac is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Women's Health, Inc.. The primary component is Bisoprolol Fumarate; Hydrochlorothiazide.

Product ID51285-047_041a5d78-d033-405a-8e2d-5ae64c0b6048
NDC51285-047
Product TypeHuman Prescription Drug
Proprietary NameZiac
Generic NameBisoprolol Fumarate And Hydrochlorothiazide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1993-10-26
Marketing CategoryNDA / NDA
Application NumberNDA020186
Labeler NameTeva Women's Health, Inc.
Substance NameBISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Active Ingredient Strength3 mg/1; mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51285-047-02

100 TABLET, FILM COATED in 1 BOTTLE (51285-047-02)
Marketing Start Date1993-10-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51285-047-02 [51285004702]

Ziac TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020186
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1993-10-26

Drug Details

Active Ingredients

IngredientStrength
BISOPROLOL FUMARATE2.5 mg/1

OpenFDA Data

SPL SET ID:238176e5-df10-457b-a5cf-c950a583e748
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 854921
  • 854916
  • 854910
  • 854919
  • 854918
  • 854908

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Increased Diuresis [PE]
    • Thiazide Diuretic [EPC]
    • Thiazides [CS]

    NDC Crossover Matching brand name "Ziac" or generic name "Bisoprolol Fumarate And Hydrochlorothiazide"

    NDCBrand NameGeneric Name
    51285-050ZiacZiac
    51285-047ZiacZiac
    51285-040ZiacZiac
    0093-3241bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    0093-3242bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    0093-3243bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    0185-0707Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    0378-0501Bisoprolol Fumarate and Hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    0378-0503Bisoprolol Fumarate and Hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    0378-0505Bisoprolol Fumarate and Hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    10135-740Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    10135-741Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    10135-742Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    10544-173bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    10544-174bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    10544-563bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide
    21695-808Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    21695-809Bisoprolol Fumarate and HydrochlorothiazideBisoprolol Fumarate and Hydrochlorothiazide
    29300-187bisoprolol fumarate and hydrochlorothiazidebisoprolol fumarate and hydrochlorothiazide

    Trademark Results [Ziac]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZIAC
    ZIAC
    74224781 1831849 Live/Registered
    TEVA WOMEN'S HEALTH, LLC
    1991-11-25
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.